

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 8.13884820 |
| 2 | synaptic vesicle maturation (GO:0016188) | 8.04630824 |
| 3 | glutamate secretion (GO:0014047) | 7.18238527 |
| 4 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 6.62740423 |
| 5 | synaptic vesicle exocytosis (GO:0016079) | 6.36493055 |
| 6 | regulation of synaptic vesicle exocytosis (GO:2000300) | 6.17491835 |
| 7 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 6.06776503 |
| 8 | cellular potassium ion homeostasis (GO:0030007) | 5.75681019 |
| 9 | regulation of synaptic vesicle transport (GO:1902803) | 5.45616916 |
| 10 | sodium ion export (GO:0071436) | 5.44493359 |
| 11 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.33848453 |
| 12 | neurotransmitter secretion (GO:0007269) | 5.22607291 |
| 13 | neuronal action potential propagation (GO:0019227) | 5.19457678 |
| 14 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.07922418 |
| 15 | locomotory exploration behavior (GO:0035641) | 4.85250248 |
| 16 | L-amino acid import (GO:0043092) | 4.75026537 |
| 17 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.70444157 |
| 18 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.64293506 |
| 19 | synaptic transmission, glutamatergic (GO:0035249) | 4.47371112 |
| 20 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.43407644 |
| 21 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 4.38990421 |
| 22 | neurotransmitter transport (GO:0006836) | 4.34980457 |
| 23 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.32677415 |
| 24 | central nervous system myelination (GO:0022010) | 4.32211347 |
| 25 | axon ensheathment in central nervous system (GO:0032291) | 4.32211347 |
| 26 | cerebellar granule cell differentiation (GO:0021707) | 4.29943994 |
| 27 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 4.28441680 |
| 28 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.28075673 |
| 29 | neuron-neuron synaptic transmission (GO:0007270) | 4.22508296 |
| 30 | exploration behavior (GO:0035640) | 4.17843416 |
| 31 | vocalization behavior (GO:0071625) | 4.16211224 |
| 32 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 4.11636535 |
| 33 | gamma-aminobutyric acid transport (GO:0015812) | 4.08961937 |
| 34 | regulation of voltage-gated calcium channel activity (GO:1901385) | 4.08783492 |
| 35 | amino acid import (GO:0043090) | 4.08575940 |
| 36 | regulation of neurotransmitter secretion (GO:0046928) | 4.04986893 |
| 37 | protein localization to synapse (GO:0035418) | 4.01845437 |
| 38 | synaptic vesicle endocytosis (GO:0048488) | 3.97957022 |
| 39 | glutamate receptor signaling pathway (GO:0007215) | 3.96547397 |
| 40 | positive regulation of synapse maturation (GO:0090129) | 3.93090778 |
| 41 | regulation of neurotransmitter levels (GO:0001505) | 3.88232145 |
| 42 | potassium ion homeostasis (GO:0055075) | 3.84304295 |
| 43 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.83613717 |
| 44 | potassium ion import (GO:0010107) | 3.80795654 |
| 45 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.78594114 |
| 46 | membrane depolarization during action potential (GO:0086010) | 3.76939889 |
| 47 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.76356022 |
| 48 | regulation of neurotransmitter transport (GO:0051588) | 3.76227796 |
| 49 | regulation of synaptic plasticity (GO:0048167) | 3.75945818 |
| 50 | neuronal ion channel clustering (GO:0045161) | 3.72142627 |
| 51 | proline transport (GO:0015824) | 3.69126975 |
| 52 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.68422557 |
| 53 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.67357875 |
| 54 | cell communication by electrical coupling (GO:0010644) | 3.65703429 |
| 55 | positive regulation of membrane potential (GO:0045838) | 3.65151641 |
| 56 | postsynaptic membrane organization (GO:0001941) | 3.63507149 |
| 57 | neurotransmitter uptake (GO:0001504) | 3.59919945 |
| 58 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.59515717 |
| 59 | neuron cell-cell adhesion (GO:0007158) | 3.59271307 |
| 60 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.58926452 |
| 61 | serotonin metabolic process (GO:0042428) | 3.57442150 |
| 62 | cellular sodium ion homeostasis (GO:0006883) | 3.54422896 |
| 63 | regulation of postsynaptic membrane potential (GO:0060078) | 3.53172893 |
| 64 | regulation of vesicle fusion (GO:0031338) | 3.51220597 |
| 65 | positive regulation of neurotransmitter transport (GO:0051590) | 3.50294960 |
| 66 | positive regulation of dendritic spine development (GO:0060999) | 3.43048560 |
| 67 | membrane depolarization (GO:0051899) | 3.36836234 |
| 68 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.35794318 |
| 69 | vesicle docking involved in exocytosis (GO:0006904) | 3.35667910 |
| 70 | dendritic spine morphogenesis (GO:0060997) | 3.35029804 |
| 71 | transmission of nerve impulse (GO:0019226) | 3.34884888 |
| 72 | long-term synaptic potentiation (GO:0060291) | 3.32471351 |
| 73 | regulation of synapse structural plasticity (GO:0051823) | 3.32390940 |
| 74 | long-term memory (GO:0007616) | 3.29800884 |
| 75 | acidic amino acid transport (GO:0015800) | 3.29415829 |
| 76 | neuromuscular process controlling posture (GO:0050884) | 3.27191808 |
| 77 | regulation of dendritic spine development (GO:0060998) | 3.26964991 |
| 78 | detection of calcium ion (GO:0005513) | 3.26155126 |
| 79 | neuromuscular process controlling balance (GO:0050885) | 3.22792785 |
| 80 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.21401331 |
| 81 | synaptic transmission (GO:0007268) | 3.20414425 |
| 82 | regulation of synaptic transmission (GO:0050804) | 3.16687879 |
| 83 | primary amino compound metabolic process (GO:1901160) | 3.16496130 |
| 84 | vesicle docking (GO:0048278) | 3.16345708 |
| 85 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.11367818 |
| 86 | regulation of synapse maturation (GO:0090128) | 3.10804611 |
| 87 | startle response (GO:0001964) | 3.09732042 |
| 88 | regulation of ARF protein signal transduction (GO:0032012) | 3.09205477 |
| 89 | establishment of synaptic vesicle localization (GO:0097480) | 3.09130004 |
| 90 | synaptic vesicle transport (GO:0048489) | 3.09130004 |
| 91 | cell communication involved in cardiac conduction (GO:0086065) | 3.03851107 |
| 92 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.01508703 |
| 93 | presynaptic membrane organization (GO:0097090) | 2.99250261 |
| 94 | adult walking behavior (GO:0007628) | 2.98004994 |
| 95 | neuromuscular synaptic transmission (GO:0007274) | 2.96929805 |
| 96 | regulation of exocytosis (GO:0017157) | 2.95748553 |
| 97 | righting reflex (GO:0060013) | 2.95414145 |
| 98 | presynaptic membrane assembly (GO:0097105) | 2.93811909 |
| 99 | L-glutamate transport (GO:0015813) | 2.93779399 |
| 100 | potassium ion transmembrane transport (GO:0071805) | 2.91889460 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.37750097 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.58511966 |
| 3 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.95186670 |
| 4 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.91164708 |
| 5 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.85147067 |
| 6 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.77773682 |
| 7 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.74725006 |
| 8 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.52076819 |
| 9 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.47529263 |
| 10 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.35782798 |
| 11 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.34884320 |
| 12 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.30508320 |
| 13 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.25017665 |
| 14 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.17225151 |
| 15 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.14210184 |
| 16 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.07871010 |
| 17 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.03278608 |
| 18 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.03278608 |
| 19 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 2.02006599 |
| 20 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.92880243 |
| 21 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.90139551 |
| 22 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.89799058 |
| 23 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.89606743 |
| 24 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.88112514 |
| 25 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.84152560 |
| 26 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.81924270 |
| 27 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.80900048 |
| 28 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.80211071 |
| 29 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.79380235 |
| 30 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.76432717 |
| 31 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.70926787 |
| 32 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.64554386 |
| 33 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.62573983 |
| 34 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.61219682 |
| 35 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.60405878 |
| 36 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.58044294 |
| 37 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.53802499 |
| 38 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.46344224 |
| 39 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.44354815 |
| 40 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.43812546 |
| 41 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.42951515 |
| 42 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.41955299 |
| 43 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.38703883 |
| 44 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.38129661 |
| 45 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.36915440 |
| 46 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.35677295 |
| 47 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.35073202 |
| 48 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.34691263 |
| 49 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.32672272 |
| 50 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.32398254 |
| 51 | P300_19829295_ChIP-Seq_ESCs_Human | 1.30713208 |
| 52 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.29614635 |
| 53 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.26797496 |
| 54 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.26494383 |
| 55 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.26185850 |
| 56 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.25426443 |
| 57 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.24765426 |
| 58 | * AR_19668381_ChIP-Seq_PC3_Human | 1.24256697 |
| 59 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.23692314 |
| 60 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.23607882 |
| 61 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.22313547 |
| 62 | * CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.18127009 |
| 63 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.14325439 |
| 64 | AR_25329375_ChIP-Seq_VCAP_Human | 1.13651998 |
| 65 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.11128955 |
| 66 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.09344176 |
| 67 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.08977514 |
| 68 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.08929905 |
| 69 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.05345410 |
| 70 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.05254714 |
| 71 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.05229468 |
| 72 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.04515776 |
| 73 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.04060660 |
| 74 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.04060660 |
| 75 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.03471288 |
| 76 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.00396909 |
| 77 | VDR_22108803_ChIP-Seq_LS180_Human | 1.00132071 |
| 78 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.99384594 |
| 79 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.98542240 |
| 80 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.98325865 |
| 81 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.97257258 |
| 82 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.97077847 |
| 83 | KDM2B_26808549_Chip-Seq_REH_Human | 0.96646944 |
| 84 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.96232934 |
| 85 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.95005833 |
| 86 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.94518165 |
| 87 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.93616068 |
| 88 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.92572020 |
| 89 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.92435199 |
| 90 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.92241241 |
| 91 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.91454616 |
| 92 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.90750428 |
| 93 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.90625915 |
| 94 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.90208226 |
| 95 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.89855003 |
| 96 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.89604269 |
| 97 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.89294844 |
| 98 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.86775671 |
| 99 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.86761485 |
| 100 | * TP53_16413492_ChIP-PET_HCT116_Human | 0.86481414 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.41631745 |
| 2 | MP0003880_abnormal_central_pattern | 5.48991467 |
| 3 | MP0004270_analgesia | 4.33273804 |
| 4 | MP0003635_abnormal_synaptic_transmissio | 4.06878052 |
| 5 | MP0002064_seizures | 3.85754340 |
| 6 | MP0009046_muscle_twitch | 3.79547042 |
| 7 | MP0009745_abnormal_behavioral_response | 3.53786480 |
| 8 | MP0005423_abnormal_somatic_nervous | 3.36468076 |
| 9 | MP0002272_abnormal_nervous_system | 3.24794608 |
| 10 | MP0002063_abnormal_learning/memory/cond | 3.20087187 |
| 11 | MP0001486_abnormal_startle_reflex | 3.18402509 |
| 12 | MP0001968_abnormal_touch/_nociception | 3.12480337 |
| 13 | MP0001501_abnormal_sleep_pattern | 2.96890989 |
| 14 | MP0002572_abnormal_emotion/affect_behav | 2.76194907 |
| 15 | MP0002734_abnormal_mechanical_nocicepti | 2.68200790 |
| 16 | MP0008569_lethality_at_weaning | 2.54781401 |
| 17 | MP0002736_abnormal_nociception_after | 2.35210189 |
| 18 | MP0003879_abnormal_hair_cell | 2.34190209 |
| 19 | MP0002735_abnormal_chemical_nociception | 2.10164370 |
| 20 | MP0009780_abnormal_chondrocyte_physiolo | 1.99293765 |
| 21 | MP0001970_abnormal_pain_threshold | 1.98615421 |
| 22 | MP0002733_abnormal_thermal_nociception | 1.97321493 |
| 23 | MP0005646_abnormal_pituitary_gland | 1.94095875 |
| 24 | MP0002067_abnormal_sensory_capabilities | 1.90798414 |
| 25 | MP0003787_abnormal_imprinting | 1.85078372 |
| 26 | MP0003329_amyloid_beta_deposits | 1.76876596 |
| 27 | MP0000920_abnormal_myelination | 1.76669236 |
| 28 | MP0003690_abnormal_glial_cell | 1.74216424 |
| 29 | MP0003633_abnormal_nervous_system | 1.71912456 |
| 30 | MP0001440_abnormal_grooming_behavior | 1.66542630 |
| 31 | MP0005386_behavior/neurological_phenoty | 1.60054851 |
| 32 | MP0004924_abnormal_behavior | 1.60054851 |
| 33 | MP0004811_abnormal_neuron_physiology | 1.59699415 |
| 34 | MP0002557_abnormal_social/conspecific_i | 1.55601365 |
| 35 | MP0006276_abnormal_autonomic_nervous | 1.53305947 |
| 36 | MP0004885_abnormal_endolymph | 1.51849447 |
| 37 | MP0001984_abnormal_olfaction | 1.48484908 |
| 38 | MP0002066_abnormal_motor_capabilities/c | 1.47804070 |
| 39 | MP0000778_abnormal_nervous_system | 1.42624364 |
| 40 | MP0001905_abnormal_dopamine_level | 1.40956383 |
| 41 | MP0003631_nervous_system_phenotype | 1.40745029 |
| 42 | MP0002882_abnormal_neuron_morphology | 1.37833505 |
| 43 | MP0001502_abnormal_circadian_rhythm | 1.30589082 |
| 44 | MP0005551_abnormal_eye_electrophysiolog | 1.28331427 |
| 45 | MP0002229_neurodegeneration | 1.26901582 |
| 46 | MP0000955_abnormal_spinal_cord | 1.26588866 |
| 47 | MP0001177_atelectasis | 1.25718627 |
| 48 | MP0004742_abnormal_vestibular_system | 1.23244795 |
| 49 | MP0010386_abnormal_urinary_bladder | 1.18747251 |
| 50 | MP0004147_increased_porphyrin_level | 1.17833663 |
| 51 | MP0002184_abnormal_innervation | 1.15957490 |
| 52 | MP0008872_abnormal_physiological_respon | 1.09735796 |
| 53 | MP0008877_abnormal_DNA_methylation | 1.07638912 |
| 54 | MP0000569_abnormal_digit_pigmentation | 1.05071638 |
| 55 | MP0001485_abnormal_pinna_reflex | 1.01954671 |
| 56 | MP0001963_abnormal_hearing_physiology | 0.99352532 |
| 57 | MP0003122_maternal_imprinting | 0.98975933 |
| 58 | MP0008874_decreased_physiological_sensi | 0.98273687 |
| 59 | MP0002638_abnormal_pupillary_reflex | 0.98005349 |
| 60 | MP0002152_abnormal_brain_morphology | 0.95647291 |
| 61 | MP0003632_abnormal_nervous_system | 0.95329520 |
| 62 | MP0003634_abnormal_glial_cell | 0.94314846 |
| 63 | MP0002822_catalepsy | 0.92388373 |
| 64 | MP0004142_abnormal_muscle_tone | 0.88516106 |
| 65 | MP0005167_abnormal_blood-brain_barrier | 0.86524852 |
| 66 | MP0000579_abnormal_nail_morphology | 0.85754157 |
| 67 | MP0001986_abnormal_taste_sensitivity | 0.81511123 |
| 68 | MP0005645_abnormal_hypothalamus_physiol | 0.80602386 |
| 69 | MP0001529_abnormal_vocalization | 0.73756036 |
| 70 | MP0001348_abnormal_lacrimal_gland | 0.72780434 |
| 71 | MP0002069_abnormal_eating/drinking_beha | 0.70905056 |
| 72 | MP0003045_fibrosis | 0.70836803 |
| 73 | MP0004043_abnormal_pH_regulation | 0.68335492 |
| 74 | MP0005535_abnormal_body_temperature | 0.67919224 |
| 75 | MP0003123_paternal_imprinting | 0.67449385 |
| 76 | MP0000604_amyloidosis | 0.66790296 |
| 77 | MP0002909_abnormal_adrenal_gland | 0.66762681 |
| 78 | MP0002752_abnormal_somatic_nervous | 0.66671007 |
| 79 | MP0003075_altered_response_to | 0.66208353 |
| 80 | MP0005623_abnormal_meninges_morphology | 0.65451314 |
| 81 | MP0004215_abnormal_myocardial_fiber | 0.64655544 |
| 82 | MP0002090_abnormal_vision | 0.61913262 |
| 83 | MP0004130_abnormal_muscle_cell | 0.59725825 |
| 84 | MP0004085_abnormal_heartbeat | 0.59420491 |
| 85 | MP0010769_abnormal_survival | 0.53495726 |
| 86 | MP0004510_myositis | 0.53226818 |
| 87 | MP0003137_abnormal_impulse_conducting | 0.52619037 |
| 88 | MP0001346_abnormal_lacrimal_gland | 0.52306040 |
| 89 | MP0001765_abnormal_ion_homeostasis | 0.51167238 |
| 90 | MP0002876_abnormal_thyroid_physiology | 0.50556197 |
| 91 | MP0010768_mortality/aging | 0.50285035 |
| 92 | MP0001299_abnormal_eye_distance/ | 0.49441709 |
| 93 | MP0002082_postnatal_lethality | 0.48800148 |
| 94 | MP0010770_preweaning_lethality | 0.48800148 |
| 95 | MP0003172_abnormal_lysosome_physiology | 0.46742624 |
| 96 | MP0004484_altered_response_of | 0.46725697 |
| 97 | MP0003956_abnormal_body_size | 0.46429209 |
| 98 | MP0005253_abnormal_eye_physiology | 0.44202245 |
| 99 | MP0000026_abnormal_inner_ear | 0.42820285 |
| 100 | MP0001943_abnormal_respiration | 0.41942955 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 8.33717234 |
| 2 | Myokymia (HP:0002411) | 7.25954962 |
| 3 | Focal seizures (HP:0007359) | 6.73866760 |
| 4 | Febrile seizures (HP:0002373) | 6.69324128 |
| 5 | Atonic seizures (HP:0010819) | 6.30023267 |
| 6 | Epileptic encephalopathy (HP:0200134) | 5.65677456 |
| 7 | Action tremor (HP:0002345) | 5.34652719 |
| 8 | Abnormality of binocular vision (HP:0011514) | 5.16772426 |
| 9 | Diplopia (HP:0000651) | 5.16772426 |
| 10 | Supranuclear gaze palsy (HP:0000605) | 4.60841303 |
| 11 | Absence seizures (HP:0002121) | 4.59453751 |
| 12 | Generalized tonic-clonic seizures (HP:0002069) | 4.53021142 |
| 13 | Dialeptic seizures (HP:0011146) | 4.51060051 |
| 14 | Progressive cerebellar ataxia (HP:0002073) | 4.29711557 |
| 15 | Ankle clonus (HP:0011448) | 4.04772883 |
| 16 | Spastic gait (HP:0002064) | 3.85059564 |
| 17 | Postural instability (HP:0002172) | 3.79252701 |
| 18 | Visual hallucinations (HP:0002367) | 3.77623925 |
| 19 | Cerebral hypomyelination (HP:0006808) | 3.54793931 |
| 20 | Papilledema (HP:0001085) | 3.53860949 |
| 21 | Abnormal eating behavior (HP:0100738) | 3.45761629 |
| 22 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.42513739 |
| 23 | Gaze-evoked nystagmus (HP:0000640) | 3.42011007 |
| 24 | Truncal ataxia (HP:0002078) | 3.41923181 |
| 25 | Neurofibrillary tangles (HP:0002185) | 3.40073057 |
| 26 | Limb dystonia (HP:0002451) | 3.27941075 |
| 27 | Dysmetria (HP:0001310) | 3.27321100 |
| 28 | Epileptiform EEG discharges (HP:0011182) | 3.19893250 |
| 29 | Hemiplegia (HP:0002301) | 3.18786577 |
| 30 | Hyperventilation (HP:0002883) | 3.18653080 |
| 31 | Torticollis (HP:0000473) | 3.14595524 |
| 32 | Status epilepticus (HP:0002133) | 3.14292531 |
| 33 | Intention tremor (HP:0002080) | 3.09812964 |
| 34 | Hemiparesis (HP:0001269) | 3.03878117 |
| 35 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.03011807 |
| 36 | Mutism (HP:0002300) | 3.02826531 |
| 37 | Delusions (HP:0000746) | 3.02283121 |
| 38 | Poor eye contact (HP:0000817) | 2.97861053 |
| 39 | Tetraplegia (HP:0002445) | 2.95589114 |
| 40 | Lower limb muscle weakness (HP:0007340) | 2.91597300 |
| 41 | Abnormality of the corticospinal tract (HP:0002492) | 2.86263328 |
| 42 | Bradykinesia (HP:0002067) | 2.77923759 |
| 43 | EEG with generalized epileptiform discharges (HP:0011198) | 2.77312734 |
| 44 | Scanning speech (HP:0002168) | 2.76875990 |
| 45 | Impaired smooth pursuit (HP:0007772) | 2.72812312 |
| 46 | Cerebral inclusion bodies (HP:0100314) | 2.71391351 |
| 47 | Urinary urgency (HP:0000012) | 2.68362405 |
| 48 | Anxiety (HP:0000739) | 2.67584150 |
| 49 | Clonus (HP:0002169) | 2.65910241 |
| 50 | Dysdiadochokinesis (HP:0002075) | 2.58546774 |
| 51 | Focal dystonia (HP:0004373) | 2.57583404 |
| 52 | Obstructive sleep apnea (HP:0002870) | 2.57242279 |
| 53 | Hypsarrhythmia (HP:0002521) | 2.54862062 |
| 54 | Broad-based gait (HP:0002136) | 2.53311175 |
| 55 | Annular pancreas (HP:0001734) | 2.53277074 |
| 56 | Depression (HP:0000716) | 2.52690194 |
| 57 | Amblyopia (HP:0000646) | 2.49832666 |
| 58 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.49420777 |
| 59 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.49420777 |
| 60 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.49377214 |
| 61 | Impaired vibratory sensation (HP:0002495) | 2.46702383 |
| 62 | Neuronal loss in central nervous system (HP:0002529) | 2.43387718 |
| 63 | Akinesia (HP:0002304) | 2.40857122 |
| 64 | Absent speech (HP:0001344) | 2.38316839 |
| 65 | Craniofacial dystonia (HP:0012179) | 2.37179263 |
| 66 | Abnormality of the lower motor neuron (HP:0002366) | 2.35898734 |
| 67 | Abnormal social behavior (HP:0012433) | 2.33843396 |
| 68 | Impaired social interactions (HP:0000735) | 2.33843396 |
| 69 | Dysmetric saccades (HP:0000641) | 2.27201060 |
| 70 | CNS hypomyelination (HP:0003429) | 2.26739317 |
| 71 | Genetic anticipation (HP:0003743) | 2.22710045 |
| 72 | Rigidity (HP:0002063) | 2.22345194 |
| 73 | Drooling (HP:0002307) | 2.21906668 |
| 74 | Increased circulating renin level (HP:0000848) | 2.15360081 |
| 75 | Bundle branch block (HP:0011710) | 2.14683149 |
| 76 | Spastic tetraparesis (HP:0001285) | 2.13747501 |
| 77 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 2.12839531 |
| 78 | Polyphagia (HP:0002591) | 2.09660406 |
| 79 | Choreoathetosis (HP:0001266) | 2.05898807 |
| 80 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.05134156 |
| 81 | Peripheral hypomyelination (HP:0007182) | 2.03036445 |
| 82 | Apathy (HP:0000741) | 2.02002899 |
| 83 | Excessive salivation (HP:0003781) | 2.01903185 |
| 84 | Sleep apnea (HP:0010535) | 1.99943817 |
| 85 | Abnormality of saccadic eye movements (HP:0000570) | 1.96598014 |
| 86 | Incomplete penetrance (HP:0003829) | 1.94246693 |
| 87 | Stereotypic behavior (HP:0000733) | 1.88424350 |
| 88 | Megalencephaly (HP:0001355) | 1.85514421 |
| 89 | Ventricular fibrillation (HP:0001663) | 1.84864510 |
| 90 | Rapidly progressive (HP:0003678) | 1.84572428 |
| 91 | Split foot (HP:0001839) | 1.84557201 |
| 92 | Amyotrophic lateral sclerosis (HP:0007354) | 1.84007378 |
| 93 | Hypokalemic alkalosis (HP:0001949) | 1.83741879 |
| 94 | Inability to walk (HP:0002540) | 1.76895056 |
| 95 | Generalized myoclonic seizures (HP:0002123) | 1.75759124 |
| 96 | Gait ataxia (HP:0002066) | 1.75304607 |
| 97 | Diminished motivation (HP:0000745) | 1.74679032 |
| 98 | Spastic paraplegia (HP:0001258) | 1.69773970 |
| 99 | Paraplegia (HP:0010550) | 1.69496608 |
| 100 | Heart block (HP:0012722) | 1.67867142 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 5.60540806 |
| 2 | NTRK3 | 4.36599597 |
| 3 | DAPK2 | 3.73460736 |
| 4 | PAK6 | 3.71348093 |
| 5 | MARK1 | 3.27330873 |
| 6 | MAP3K9 | 2.68262111 |
| 7 | NTRK2 | 2.48998091 |
| 8 | UHMK1 | 2.41772110 |
| 9 | MINK1 | 2.21183533 |
| 10 | CASK | 2.08496468 |
| 11 | PLK2 | 2.03912030 |
| 12 | CAMKK1 | 2.03224850 |
| 13 | GRK5 | 2.03061937 |
| 14 | PRKD3 | 1.96355370 |
| 15 | NTRK1 | 1.91632738 |
| 16 | FRK | 1.83987700 |
| 17 | LATS2 | 1.80149881 |
| 18 | DAPK1 | 1.67921588 |
| 19 | MAPK13 | 1.66821262 |
| 20 | CDK5 | 1.58003346 |
| 21 | PINK1 | 1.53039527 |
| 22 | CAMK1 | 1.50142292 |
| 23 | PRKCG | 1.41078644 |
| 24 | CAMKK2 | 1.39628559 |
| 25 | RIPK4 | 1.38133743 |
| 26 | CAMK2B | 1.37806598 |
| 27 | PAK3 | 1.37118574 |
| 28 | ARAF | 1.31779270 |
| 29 | MAP3K4 | 1.30177471 |
| 30 | PHKG2 | 1.21414565 |
| 31 | PHKG1 | 1.21414565 |
| 32 | STK38 | 1.17380618 |
| 33 | CAMK2A | 1.16648535 |
| 34 | OXSR1 | 1.16637519 |
| 35 | SGK494 | 1.11902650 |
| 36 | SGK223 | 1.11902650 |
| 37 | PRKCH | 1.09780618 |
| 38 | KSR2 | 1.09451257 |
| 39 | SIK2 | 1.07401271 |
| 40 | NEK6 | 1.02959302 |
| 41 | BMPR2 | 1.02536242 |
| 42 | SGK2 | 0.98807723 |
| 43 | CDK18 | 0.97873719 |
| 44 | CDK15 | 0.97657235 |
| 45 | TYRO3 | 0.97211134 |
| 46 | CDK19 | 0.96656058 |
| 47 | DYRK1A | 0.92105015 |
| 48 | CDK14 | 0.87021016 |
| 49 | CDK11A | 0.85676140 |
| 50 | CAMK2G | 0.84760806 |
| 51 | PKN1 | 0.83715497 |
| 52 | MAP3K12 | 0.82497890 |
| 53 | CCNB1 | 0.79340342 |
| 54 | SGK3 | 0.78389792 |
| 55 | PTK2B | 0.77243750 |
| 56 | STK11 | 0.76030335 |
| 57 | PDK1 | 0.75519091 |
| 58 | SGK1 | 0.72677828 |
| 59 | RIPK1 | 0.69689748 |
| 60 | MAP2K7 | 0.69687410 |
| 61 | MAPK12 | 0.67798716 |
| 62 | LMTK2 | 0.66484992 |
| 63 | MAPK10 | 0.65880318 |
| 64 | STK39 | 0.63722400 |
| 65 | PRKCE | 0.63632641 |
| 66 | CAMK4 | 0.61402588 |
| 67 | MAP3K2 | 0.61122462 |
| 68 | MAP3K13 | 0.60228572 |
| 69 | CAMK2D | 0.59438384 |
| 70 | MARK2 | 0.58681664 |
| 71 | WNK1 | 0.58123345 |
| 72 | CSNK1G2 | 0.57270252 |
| 73 | LIMK1 | 0.57063749 |
| 74 | RPS6KA3 | 0.55499713 |
| 75 | MAP2K4 | 0.53732609 |
| 76 | BRSK1 | 0.52636142 |
| 77 | FGFR2 | 0.51606477 |
| 78 | PDPK1 | 0.51049165 |
| 79 | PNCK | 0.50285918 |
| 80 | ALK | 0.48454325 |
| 81 | MAPKAPK5 | 0.47822127 |
| 82 | KSR1 | 0.47562370 |
| 83 | ROCK2 | 0.46503801 |
| 84 | RAF1 | 0.45309068 |
| 85 | CAMK1G | 0.44647723 |
| 86 | MAP2K1 | 0.43699024 |
| 87 | DAPK3 | 0.42767364 |
| 88 | AKT3 | 0.42065426 |
| 89 | PRKCA | 0.41371726 |
| 90 | FYN | 0.39862048 |
| 91 | TNK2 | 0.37748079 |
| 92 | PRPF4B | 0.37282546 |
| 93 | PRKCZ | 0.36778712 |
| 94 | PRKG1 | 0.35753844 |
| 95 | MOS | 0.34214525 |
| 96 | ROCK1 | 0.33622302 |
| 97 | BRAF | 0.33492187 |
| 98 | PRKCB | 0.33406875 |
| 99 | ADRBK2 | 0.33247717 |
| 100 | CSNK1D | 0.32046774 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 4.36111176 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.91257263 |
| 3 | GABAergic synapse_Homo sapiens_hsa04727 | 2.91304966 |
| 4 | Circadian entrainment_Homo sapiens_hsa04713 | 2.82440341 |
| 5 | Long-term potentiation_Homo sapiens_hsa04720 | 2.80070798 |
| 6 | Morphine addiction_Homo sapiens_hsa05032 | 2.79837669 |
| 7 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.73973137 |
| 8 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.68424117 |
| 9 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.64477794 |
| 10 | Insulin secretion_Homo sapiens_hsa04911 | 2.50852698 |
| 11 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.26450454 |
| 12 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.17537662 |
| 13 | Gastric acid secretion_Homo sapiens_hsa04971 | 2.15315609 |
| 14 | Salivary secretion_Homo sapiens_hsa04970 | 2.13173084 |
| 15 | Cocaine addiction_Homo sapiens_hsa05030 | 1.95892097 |
| 16 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.82913602 |
| 17 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.81954953 |
| 18 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.73491078 |
| 19 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.72703967 |
| 20 | Taste transduction_Homo sapiens_hsa04742 | 1.71632416 |
| 21 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.67254306 |
| 22 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.65192895 |
| 23 | Renin secretion_Homo sapiens_hsa04924 | 1.61781257 |
| 24 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.61005055 |
| 25 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.50675360 |
| 26 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.46675140 |
| 27 | Long-term depression_Homo sapiens_hsa04730 | 1.40827465 |
| 28 | Olfactory transduction_Homo sapiens_hsa04740 | 1.39417183 |
| 29 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.38276157 |
| 30 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.34322317 |
| 31 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.33004815 |
| 32 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.31162488 |
| 33 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.30499066 |
| 34 | Phototransduction_Homo sapiens_hsa04744 | 1.25425892 |
| 35 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.17758815 |
| 36 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.12826889 |
| 37 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.10225052 |
| 38 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.09012594 |
| 39 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.08417695 |
| 40 | Glioma_Homo sapiens_hsa05214 | 1.07131087 |
| 41 | Gap junction_Homo sapiens_hsa04540 | 1.05556138 |
| 42 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.03570936 |
| 43 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.93240249 |
| 44 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.92735427 |
| 45 | Circadian rhythm_Homo sapiens_hsa04710 | 0.86758813 |
| 46 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.86331397 |
| 47 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.84893344 |
| 48 | Bile secretion_Homo sapiens_hsa04976 | 0.83904782 |
| 49 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.83877058 |
| 50 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.83405380 |
| 51 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.82909519 |
| 52 | Melanogenesis_Homo sapiens_hsa04916 | 0.82078064 |
| 53 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.80749974 |
| 54 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.78774347 |
| 55 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.77674397 |
| 56 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.73098775 |
| 57 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.70135978 |
| 58 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.70098431 |
| 59 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.68532401 |
| 60 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.68353096 |
| 61 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.67876891 |
| 62 | Axon guidance_Homo sapiens_hsa04360 | 0.62180962 |
| 63 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.62110894 |
| 64 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.60746161 |
| 65 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.58307306 |
| 66 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.57920965 |
| 67 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.56709937 |
| 68 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.54552107 |
| 69 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.52417559 |
| 70 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.52067350 |
| 71 | Histidine metabolism_Homo sapiens_hsa00340 | 0.49885924 |
| 72 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.49383396 |
| 73 | Endocytosis_Homo sapiens_hsa04144 | 0.47143799 |
| 74 | Mineral absorption_Homo sapiens_hsa04978 | 0.46900740 |
| 75 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.46672724 |
| 76 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.46505485 |
| 77 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.46476356 |
| 78 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.45827998 |
| 79 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.44781801 |
| 80 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.40517647 |
| 81 | Alcoholism_Homo sapiens_hsa05034 | 0.37397268 |
| 82 | Platelet activation_Homo sapiens_hsa04611 | 0.35942226 |
| 83 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.35614085 |
| 84 | ABC transporters_Homo sapiens_hsa02010 | 0.34875985 |
| 85 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.34036994 |
| 86 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.33319398 |
| 87 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.33308757 |
| 88 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.32934481 |
| 89 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.32607212 |
| 90 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.30821732 |
| 91 | Prion diseases_Homo sapiens_hsa05020 | 0.28054970 |
| 92 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.27049660 |
| 93 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.25796781 |
| 94 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.23094500 |
| 95 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.22571097 |
| 96 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.22082983 |
| 97 | Tight junction_Homo sapiens_hsa04530 | 0.21594284 |
| 98 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.21200555 |
| 99 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.17683952 |
| 100 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.17013213 |

